Table 2.

Adverse Events of R-CHOP Therapy

	Patients aged above 60 years (n=43) any AE/AE ≥grade 3	Patients aged above 70 years (n=26) any AE/AE ≥grade 3
Adverse events (n, %)
Infusion reaction	6/0 (14/0)	3/0 (12/0)
Neutropenia	42/42 (98/98)	25/25 (96/96)
Neuropathy	13/0 (30/0)	8/0 (31/0)
Nausea	13/0 (30/0)	6/0 (23/0)
Vomiting	5/0 (12/0)	2/0 (8/0)
Pneumonia	17/2 (37/4)	10/2 (31/8)
Esophagitis	28/0 (64/0)	15/0 (58/0)
Mucositis, oral	6/0 (14/0)	4/0 (15/0)
Dry mouth	5/0 (12/0)	3/0 (12/0)
Skin disorders	7/0 (16/0)	3/0 (12/0)

Adverse events were graded based on Common Terminology Criteria for Adverse Events version 4.0.